已收盤 08-01 16:00:00 美东时间
-0.630
-1.45%
Ag Growth International press release (TSX:AFN:CA): Q2 Revenue of $349M. Adjusted EBITDA1 of $54 million, towards the high-end of the $50-$55 million outlook provided by AGI Adjusted EBITDA margin %2...
08-01 05:54
Howmet Aerospace Inc. (NYSE: HWM) reported record revenue & profit in Q2 2025, exceeding guidance & strengthening its position in aerospace & defense.
07-31 23:34
Larimar Therapeutics, Inc. completed an underwritten public offering of 21.56 million shares of its common stock, including 2.81 million additional shares, at $3.20 per share, raising $69 million in gross proceeds. The company plans to use the funds to develop its pipeline, including nomlabofusp for Friedreich’s ataxia, and for general corporate purposes.
07-31 20:15
LATAM Airlines Group SA Sponsored ADR ( ($LTM) ) has issued an update. On July ...
07-31 02:17
(来源:维科网机器人) 7月31日论坛启幕,欢迎报名参与 距离全数会 2025 AI 赋能工业制造与机器人融合发展论坛召开,倒计时 3 天! 7 月...
07-30 19:31
Larimar Therapeutics has launched an underwritten public offering of its common stock and pre-funded warrants, with underwriters holding a 30-day option to purchase up to 15% more securities. Net proceeds will support the development of nomlabofusp and other pipeline candidates, as well as general corporate purposes. Leerink Partners and Guggenheim Securities are joint bookrunning managers. The offering is subject to market conditions and SEC reg...
07-29 20:01
American Express (NYSE:AXP) stock fell 2.6% in Friday midday trading as the credit card company's core pre-provision net revenue (NNPR) fell short of Wall Street expectations. New card acquisitions al...
07-19 00:21
7月初,协作设计平台Figma向SEC递交了S-1招股说明书,拟以“FIG”为代号在纽交所上市。作为一度被Adobe高价收购又中止交易的明星独角兽,Figma此...
07-15 17:49
<p>Larimar Therapeutics has published two peer-reviewed articles detailing nonclinical data on nomlabofusp, a potential treatment for Friedreich’s ataxia. The studies demonstrate the drug's mechanism of action, its ability to increase FXN protein levels in key tissues, and support the use of skin FXN concentrations as a surrogate endpoint for accelerated approval. The company plans to submit a BLA for nomlabofusp in Q2 2026.</p>
07-08 11:00
LATAM Airlines Group SA Sponsored ADR ( ($LTM) ) has issued an announcement. On...
07-02 04:55